15:59:39 RRSAgent has joined #HCLS 15:59:39 logging to http://www.w3.org/2012/11/21-HCLS-irc 15:59:47 Meeting: W3C HCLS – Clinical Pharmacogenomics 15:59:52 Chair: Michel Dumontier 16:01:25 matthias_samwald has joined #hcls 16:02:22 boycerd has joined #HCLS 16:05:08 michel: new directions to solution problems 16:05:43 rich: working on clinical proposal - product labeling; solidify the resource, making it useful for NLP folks. links back to the LOD 16:06:37 ... drug interactions and pharmacogenomics; colleagues in school of pharmacy, pgx guidelines of interest; pharmacy-specific use cases 16:07:21 ... going to brainstorm specific tasks in next meeting 16:07:29 ... modeling the semantics of pgx claims in product labels 16:07:51 ... have a semantic model to capture 29 statements from product labels 16:09:02 michel: sounds really good - looking forward to the requirements, and determine how we can support or collaborate in this work 16:09:12 matthias: what semantic model are you referring to? 16:09:25 pkc_nh has joined #hcls 16:09:46 rich: met with clinical pharmacology and pharmacy people to pull out pgx sections and developed a model rather organically 16:10:47 bob: working with rich for a few months to structure some of the product labels, in a way that we can access and mine 16:11:20 ... will be really useful with the linked data clouds, like pharmgkb 16:12:24 lots of typing noise! 16:13:56 leaving now, happy thanksgiving. 16:14:36 bye rich! 16:15:04 bob: amia group - significant interest in clinical pharmacogenomics. overlap - could grow our ranks to advertise to that channel 16:15:12 michel +1 16:16:05 matthias: the additional focus will help to bring more people to the table 16:16:09 bob: graduate students 16:16:25 matthias; one goal should be to align our interests 16:17:18 rich: work that matthias presented on 2d bar codes - really neat application. would like to consider how to apply this more broadly to other knowledge sources 16:17:27 sorry - bob said the above 16:18:15 bob: hla application is ripe for this - number of loci should be containable in the bar code, but extreme variety in the population 16:18:47 bob: blood typing? 16:19:22 bob: would like to think of additional ways in which we can coordinate that 16:20:46 paul courtney - dana farber cancer institute - blood and marrow transplant group there; hla typing is really important. how we match donors with recipients. 16:21:55 matthias: definitely applicable 16:22:18 bob: invovled in national bone marrow donor program 16:24:56 matthias: a standard - shared ontology, shared design pattern - for representing pgx / immunogenetic data 16:25:14 lost my connection 16:25:22 me too 16:26:03 back on again 16:28:42 bob: structured product labels - the pgx section is a big paragraph of (mixed) text; knowledge is completely unstructured. e.g authors can say whatever they want about gene interactions - just an association with a gene and drug, or it could be a specific allele 16:29:02 ... how can we mark this up so they can be mined later 16:30:01 bob: rich has a tool to extract triples out of the markup; however, they vary enormously about what they say 16:30:27 matthias: manual annotation is really required 16:30:30 bob: +1 16:32:20 bob: at the point where we can take the resource and find associations between genes and drugs; but more detailed evidence of the nature of the interaction is not guaranteed 16:32:55 paul: is it that pharma just doesn't have access to that information to provide more specific details? 16:33:14 achille_z has joined #hcls 16:33:20 bob: personal opinion - not an unwillingness to share the information - but it's up to the label author to make an assertion without all the evidence 16:34:05 ... don't want to make an incorrect assertion - it may be more prudent to state the association 16:34:59 michel: cds ontology 16:35:17 matthias: genomic cds ontology http://www.genomic-cds.org/ont/genomic-cds.owl 16:35:33 ... demo with patient data: http://www.genomic-cds.org/ont/genomic-cds-demo.owl 16:37:09 ... extracted data from dbsnp and pharmgkb, ontology that contains the snps and logical definitions 16:37:55 ... clinical guidelines are represented - 50 separate rules to match specific patient profile with specific clinical guidelines 16:38:16 ... some guidelines refer to snps, alleles and genotypes 16:38:23 ... with the ontology, can infer one from the other 16:38:40 - +1.507.269.aabb 16:38:59 zakim, +aadd is michel 16:38:59 sorry, michel, I do not recognize a party named '+aadd' 16:39:06 zakim, .aadd is michel 16:39:06 sorry, michel, I do not recognize a party named '.aadd' 16:39:12 zakim, aadd is michel 16:39:12 +michel; got it 16:39:58 ... open question on how to represent phasing rules in the ontology; ambiguous combination of snps; 16:40:06 ... missing representation of copy number variations 16:40:19 ... ontology assumes one copy of each allele on each strand 16:40:30 ... CNV have significant clinical impact 16:40:44 ... more information about genetic assays for testing specific alleles 16:41:03 ... process for annotating the rules and extracting the data need to be automated; better provenance 16:42:20 ... in the email, definitions provided in owl manchester syntax; possible to have a sentence and generate an axiom 16:42:44 bob: great work ! 16:44:23 michel: +1 16:44:38 matthias: mostly script generated. uses dbsnp service to get more information 16:45:10 matthias: uses 2 excel spreadsheets - allele/haplotype definitions from pharmgkb; clinical decision support rules that were manually curated 16:45:25 ... spreadsheets make it possible for domain experts to validate 16:45:35 ... move this to google doc and collaborate 16:51:33 michel: michel asks bob what the status of the clinical guidelines are 16:51:48 bob: developed a information model for the guidelines, currently evaluating it 16:52:31 bob: hope to have one of those CPIC guidelines in a structured format 16:52:36 ... by the end of the year 16:53:37 bob: captures detailed information about the guidelines - includes link outs 16:54:10 ... as specific and necessary to capture that important information, but general enough to capture numerous different guidelines 16:54:29 ... just wants to convince himself about the approach 16:55:05 matthias: drug + genetic markers + evidence - just basic info 16:56:25 bob: guideline with hlad genotype; needs revision; until i get to fix this, i want to keep working on it, but will present asap 17:00:00 bob: HL7 clinical genomics group? 17:01:22 matthias: conflicting / heterogeneous / overlapping projects ; 17:03:08 ericP: CDA (xml representation of v3 (RIM) concepts), FHIR (based on v3); similar, but a number of false equivalences between these. RIM is like an upper level ontology 17:04:45 bob: use cases that hl7 clinical genomics could be used for us 17:06:15 michel/ericp: in theory we could use FHIR data to translate into genomic-cds 17:06:38 -Tony 17:06:41 -michel 17:06:42 - +1.240.753.aaee 17:06:50 rrsagent, draft minutes 17:06:50 I have made the request to generate http://www.w3.org/2012/11/21-HCLS-minutes.html michel 17:06:56 rrsagent, make log world-visible 17:10:13 -ericP 17:10:24 -[IPcaller] 17:10:25 SW_HCLS(LODD)11:00AM has ended 17:10:25 Attendees were [IPcaller], +1.613.293.aaaa, +1.507.269.aabb, +1.240.753.aacc, +1.613.293.aadd, +1.240.753.aaee, Tony, ericP, michel 17:26:30 egonw_ has joined #HCLS 18:56:32 Zakim has left #HCLS 21:20:12 egonw_ has joined #HCLS